DCPH

Deciphera Pharmaceuticals Stock Price

54.2705
0.0305 (0.06%)
Upgrade to Real-Time
Afterhours (Closed)
54.24
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Deciphera Pharmaceuticals Inc DCPH NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.49 -0.9% 54.24 53.60 54.86 54.26 54.73 19:53:40
Bid Price Ask Price Spread Spread % News
53.75 62.00 8.25 13.31% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5,293 282,142 $ 54.24 $ 15,304,531 563,472 19.88 - 71.11
Last Trade Time Type Quantity Stock Price Currency
16:11:01 average 100 $ 54.2705 USD

Deciphera Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.03B 55.86M 39.15M $ 25.00M $ - -4.45 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 374.00 0.40%

more financials information »

Deciphera Pharmaceuticals News

Date Time Source News Article
7/06/202018:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
7/02/202016:01Business WireDeciphera Announces Presentation of Analysis of Crossover..
6/22/202007:00Business WireDeciphera Announces Health Canada’s Authorization of..
6/12/202016:07Edgar (US Regulatory)Current Report Filing (8-k)
6/12/202016:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
6/12/202016:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
6/12/202016:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical DCPH Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week56.8057.98553.5555.29446,663-2.56-4.51%
1 Month53.8766.1252.3459.24624,2110.370.69%
3 Months44.7266.1244.1856.16519,6729.5221.29%
6 Months62.8571.1133.1053.11561,835-8.61-13.7%
1 Year22.3771.1119.8846.90603,51131.87142.47%
3 Years20.0571.1115.1538.78365,04834.19170.52%
5 Years20.0571.1115.1538.78365,04834.19170.52%

Deciphera Pharmaceuticals Description

Deciphera Pharmaceuticals Inc is a biotechnology company, which develops and manufactures kinase-inhibiting drugs for the treatment of cancers and immunological diseases. It holds a diverse pipeline of drug candidates that includes three clinical-stage and two research-stage programs. Its lead drug candidate DCC-2618 is designed to inhibit the full spectrum of mutant or amplified KIT and Pdgfra kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. In addition it is also developing two other clinical-stage drug candidates, DCC-3014 and Rebastinib.
Your Recent History
NASDAQ
DCPH
Deciphera ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200711 14:56:40